Purpose: One of the factors preventing clinical application of regenerative medicine to degenerative cartilage diseases is a suitable source of cells. Cartilage tissue is sparsely cellular and chondrocytes are the only cell type but under in vitro culture conditions they lose their phenotype along with the ability to generate hyaline cartilaginous tissue. Here we describe a reliable serum and growth factor free culture system to reverse this change in phenotype. Methods: Bovine articular chondrocytes (BAC) were passaged twice to allow for cell number expansion (P2) and cultured at high density on 3D collagen type II-coated membranes in media supplemented with ITS+ with 4.5g/l glucose, proline and 10-8 M dexamethasone (SF3D). Cultures were grown for up to 4 weeks. Inhibition studies were initiated on day 2 with 100uM HNMPA-(AM3). For FACS cells were harvested with Trypsin, stained with antibodies reactive with CD105-PE or CD44-PE (eBioscience, US) and analyzed by EPICS XL FACS and Kaluza analysis software (Beckman Coulter, US). ChIP-qPCR was carried out after in-situ cross-linking with 0.75% formaldehyde. Cells were sonicated in 1% Triton-100 and 1% SDS lysis buffer (Vibracell 30sec ON and 60sec OFF, 20x) and 250-900 bp DNA fragmentation was confirmed by agarose gel electrophoresis. Purified DNA was analyzed by qPCR using primers within the enhancer region of COL2A1. For immunoprecipitation cells were extracted in Ripa buffer and incubated with Sox9 antibody, the immune complex was harvested with Protein A/G beads. Extracts were immunoblotted with antibodies reactive with Sox6 and Med12. Results: 99% of P2 cells in monolayer culture were CD44+ and 40% were CD105+. They showed differential gene expression with high type 1 collagen and low type II collagen. Gene expression of other cartilage associated genes was lower in P2 cells when compared with the primary P0 chondrocytes. When placed in SF3D the P2 cells expressed chondrogenic genes and accumulated extracellular matrix (ECM) rich in proteoglycans (PGs) and type II collagen. Decreasing insulin receptor (IR) with HNMPA-(AM3) inhibited collagen and PGs synthesis and reduced expression of col II, col XI, IR and IGF1R genes as well as Sox6 and 9 proteins. Co-IP and ChIP analysis on inhibited cells showed binding of co-activators Sox6 and Med12 with Sox9 but reduced Sox9-Col2A1 binding. Figure 1 . Photomicrographs of the tissue formed by P2 when cultured in SC3D culture show no matrix accumulation (far left panel) SF3D show accumulation of matrix rich in PGs evident by Toluidine Blue staining (second panel). SF3D tissue stained positively for collagen type II (red) and were predominantly negative for collagen type I (green) (third panel) similar to native cartilage tissue stained with the same antibodies (fourth panel). Conclusions: Here we describe a novel serum/ xenogeneic compound/ growth factor-free culture system which promotes hyaline-like cartilage tissue formation by insulin mediated regulation of Sox9-Col2A1 binding. This is a critical step towards the ultimate goal of developing autologous patient specific tissue engineered hyaline-like cartilage tissue suitable to use for repair/replacement of damaged articular cartilage. The suitability of this system for use in regenerative medicine approaches needs to be examined in vivo. Acknowledgements: Supported by DoD.
Purpose: One of the factors preventing clinical application of regenerative medicine to degenerative cartilage diseases is a suitable source of cells. Cartilage tissue is sparsely cellular and chondrocytes are the only cell type but under in vitro culture conditions they lose their phenotype along with the ability to generate hyaline cartilaginous tissue. Here we describe a reliable serum and growth factor free culture system to reverse this change in phenotype. Methods: Bovine articular chondrocytes (BAC) were passaged twice to allow for cell number expansion (P2) and cultured at high density on 3D collagen type II-coated membranes in media supplemented with ITS+ with 4.5g/l glucose, proline and 10-8 M dexamethasone (SF3D). Cultures were grown for up to 4 weeks. Inhibition studies were initiated on day 2 with 100uM HNMPA-(AM3). For FACS cells were harvested with Trypsin, stained with antibodies reactive with CD105-PE or CD44-PE (eBioscience, US) and analyzed by EPICS XL FACS and Kaluza analysis software (Beckman Coulter, US). ChIP-qPCR was carried out after in-situ cross-linking with 0.75% formaldehyde. Cells were sonicated in 1% Triton-100 and 1% SDS lysis buffer (Vibracell 30sec ON and 60sec OFF, 20x) and 250-900 bp DNA fragmentation was confirmed by agarose gel electrophoresis. Purified DNA was analyzed by qPCR using primers within the enhancer region of COL2A1. For immunoprecipitation cells were extracted in Ripa buffer and incubated with Sox9 antibody, the immune complex was harvested with Protein A/G beads. Extracts were immunoblotted with antibodies reactive with Sox6 and Med12. Results: 99% of P2 cells in monolayer culture were CD44+ and 40% were CD105+. They showed differential gene expression with high type 1 collagen and low type II collagen. Gene expression of other cartilage associated genes was lower in P2 cells when compared with the primary P0 chondrocytes. When placed in SF3D the P2 cells expressed chondrogenic genes and accumulated extracellular matrix (ECM) rich in proteoglycans (PGs) and type II collagen. Decreasing insulin receptor (IR) with HNMPA-(AM3) inhibited collagen and PGs synthesis and reduced expression of col II, col XI, IR and IGF1R genes as well as Sox6 and 9 proteins. Co-IP and ChIP analysis on inhibited cells showed binding of co-activators Sox6 and Med12 with Sox9 but reduced Sox9-Col2A1 binding. Figure 1 . Photomicrographs of the tissue formed by P2 when cultured in SC3D culture show no matrix accumulation (far left panel) SF3D show accumulation of matrix rich in PGs evident by Toluidine Blue staining (second panel). SF3D tissue stained positively for collagen type II (red) and were predominantly negative for collagen type I (green) (third panel) similar to native cartilage tissue stained with the same antibodies (fourth panel). Conclusions: Here we describe a novel serum/ xenogeneic compound/ growth factor-free culture system which promotes hyaline-like cartilage tissue formation by insulin mediated regulation of Sox9-Col2A1 binding. This is a critical step towards the ultimate goal of developing autologous patient specific tissue engineered hyaline-like cartilage tissue suitable to use for repair/replacement of damaged articular cartilage. The suitability of this system for use in regenerative medicine approaches needs to be examined in vivo. Acknowledgements: Supported by DoD. Purpose: Joint distraction is extensively studied in osteoarthritis and found to be very effective in diminishing pain and improving joint function. Uniquely, this treatment also results in actual joint tissue repair as proven by MRI, X-ray and biomarker analyses (Intema et al., Ann Rheum Dis 2011) . With this treatment a prosthesis or arthrodesis can be delayed which is especially of value for younger patients (<65 years). This promising treatment can be a good alternative treatment for patients with haemophilic arthropathy who regularly need joint replacement of their affected joint or arthrodesis on a very young age (<40 years). In severe haemophilic ankle arthropathy, the standard surgical treatment options are fusion of the tibiotalar joint and total ankle replacement. Both treatments have complications and therefore an alternative treatment as joint distraction is desired. In this study, treatment of haemophilic ankle arthropathy with joint distraction was explored for the first time. Methods: Three patients with haemophilic ankle arthropathy were treated with joint distraction using an Ilizarov external fixator for 10-15 weeks. After 1.7-3.4 years clinical outcomes like function, participation and pain were evaluated in retrospect with different questionnaires: haemophilia activities list (HAL), impact on participation and autonomy (IPA) and the Van Valburg questionnaire. Post-operative ankle joint mobility was measured. Structural changes were assessed blinded on Xray by the Pettersson score and ankle images digital analysis (AIDA) and by an MRI score. Results: All three patients were very satisfied with the clinical outcome of the procedure. They reported a clear improvement for selfperceived functional health (mean HAL sum score improved from 44AE28.4% to 73AE17.7% (p¼0.04)), impact on participation and autonomy (statistically significant improvement on the domains family role, autonomy outdoors and work & participation (p¼0.014; p¼0.014 and p¼0.046 respectively)) and pain (mean VAS score decreased from 80AE5.0% before distraction to 23AE15.3% after distraction (p¼0.016)). Partial ankle joint mobility was preserved in the three patients. The Pettersson score remained the same in one patient and slightly improved in the two other patients. The mean joint space width measured by AIDA increased from 2.3AE1.8 mm to 3.4AE1.0mm (p¼0.07) and the MRI score demonstrated improvement for all three patients after ankle distraction (pre-treatment 12.0AE3.5; post-treatment 8.0AE4.4 (p¼0.020)). Conclusion: Although retrospective of nature, this study suggests that joint distraction is also a promising treatment for individual cases of haemophilic ankle arthropathy, without additional risk of bleedings during treatment. These results warrant further prospective studies on joint distraction as treatment for haemophilic arthropathy. Purpose: Stem cells are an important resource for tissue repair and regeneration. The organization of signaling molecules in the stem cell membrane likely plays an important, but incompletely understood, role in governing stem cell phenotype and responsiveness to external stimuli. We have recently demonstrated that caveolin-1 (Cav-1) acts to inhibit osteogenesis of human bone marrow derived mesenchymal stem cells (MSCs). Cav-1 is a scaffolding protein of caveolae lipid rafts of the plasma membrane with an affinity for many signaling molecules. Others have shown that caveolar endocytosis of activated integrins contributes to the repression of rat MSC osteogenesis on soft matrices, at least partially by the co-internalization of BMP receptors. Given that caveolae are capable of integrin internalization, integrin focal adhesion signaling activates Akt, and Cav-1 is known to bind to Akt, we hypothesize that Cav-1 inhibition of osteogenesis may be mediated via repressing Akt signaling. The purpose of this study was to test the relationship between Akt signaling, Cav-1 and lipid rafts during MSC osteogenesis. Methods: MSCs were isolated from the bone marrow of femoral heads obtained following total hip replacement surgery with IRB approval. MSCs with or without disruption to Cav-1 expression (using siRNA), lipid rafts (using methyl-b-cyclodextrin, MbCD) or PI3K/Akt signaling (using the inhibitor LY294002) were cultured in growth medium with 10% FBS (GM) or GM supplemented with 5 mM b-glycerophosphate, 50 mg/ml ascorbate, 10 nM 1,25-dihydroxyvitamin D3, and 10 nM dexamethasone (OM) to induce osteogenesis. Total cell lysates were collected in RIPA buffer at short time intervals after initial addition of GM or OM to determine Akt activity. Osteogenesis was assessed on the basis of alkaline phosphatase (ALP) activity using p-nitrophenylphosphate substrate on day 4, and by alizarin red staining for matrix mineralization on day 21. Caveolae and non-caveolar lipid rafts were isolated from cells grown for 10 days in GM or OM using a sucrose density centrifugation method. The gradient fractions were harvested and probed for Cav-1 and Akt by western blotting. Results: As previously described, upon culturing in OM, MSCs with siRNA-mediated Cav-1 knockdown showed enhanced osteogenesis, i.e., increased ALP activity and alizarin red staining, compared to control MSCs. Akt phosphorylation was seen 30 min after the addition of OM, but it was unclear if this signaling was enhanced in MSCs with reduced Cav-1 expression due to MSC donor variation. LY294002 completely abolished Akt phosphorylation, and significantly reduced ALP activity and alizarin red staining induced by OM in a dose dependent manner. Pre-treatment of MSCs with MbCD also dose dependently inhibited ALP activity induced by OM. Akt was detected in lipid rafts, more to non-caveolar lipid rafts than to caveolae, and its abundance in lipid rafts seemed to be elevated in osteogenically differentiating MSCs. Conclusion: These results show: (1) the involvement of PI3K/Akt signaling in MSC osteogenesis, because OM induced Akt phosphorylation and osteogenesis were both inhibited by the PI3K inhibitor LY294002; (2) the requirement of membrane cholesterol in MSC osteogenic differentiation, as MbCD, which binds to and removes cholesterol from cell membranes, inhibited osteogenesis; and (3) the concentration of Akt in non-caveolar cholesterol-rich lipid rafts during MSC osteogenesis, because Akt was immunoblot-detected in lipid rafts and appeared more abundant in non-caveolar lipid rafts in response to OM. We are currently investigating the dependence of pro-osteogenic PI3K/Akt signaling on membrane cholesterol, and whether Akt localized to caveolae is inhibited by Cav-1, a known suppressor of osteogenesis. Purpose: ADAMTS5 (aggreacanase-2) is known to be a crucial proteinase that degrades articular cartilage during osteoarthritis (OA) development. To elucidate the molecular network as a therapeutic target of OA, the present study attempted to identify transcription factors to induce ADAMTS5 expression and to examine the underlying mechanism.
Methods: Sequences of about 2 kb of 5'-end flanking regions were compared among human, macaca, and mouse ADAMTS5 genes. The sequence search predicted the consensus binding motifs in the conserved region among species. Promoter activities were determined in mouse chondrogenic ATDC5 cells transfected with a luciferasereporter gene containing the fragments. Protein-DNA binding was examined by electrophoretic mobility shift assay. Endogenous Adamts5 expression was examined by real-time RT-PCR using ATDC5 cells and primary chondrocytes isolated from mouse articular cartilage. Aggrecanolysis was investigated by measuring aggrecan fragments released into culture medium in ex vivo cultures of 3-week-old mouse femoral head cartilage. In vivo localization was examined by immunohistochemistry in the experimental OA model by surgical induction of instability in the knee joints of 8-week-old mice Results: Exhaustive comparison of the genomic sequences of human, macaca, and mouse ADAMTS5 genes revealed that the 1.4 kb region upstream of the transcriptional start site was highly conserved among the species. The sequence search in this region predicted the consensus binding motifs of NF-kB, C/EBP, GATA, RUNX, AP-1, OCT, SOX, STAT, and HIF. We then created expression vectors of 26 putative transcription factors that are known to bind to these sites, and transfected them in ATDC5 cells with a luciferase construct containing the 1.4 kb ADAMTS5 fragment. Among the transcription factors, an NF-kB family member RelA/p65 most strongly stimulated the promoter activity. In the ADAMTS5 genes, there were three NF-kB binding motifs: À1,196/À1,187, À896/À887, and À424/À415 bp, in which deletion, mutagenesis, and tandem-repeat analyses of the luciferase assay identified the core responsive regions of RelA/p65 to be the two upstream motifs. These two NF-kB motif oligonucleotide probes were confirmed to bind to nuclear extracts of RelA/p65-overexpressing COS-7 cells. The specificity of binding was verified by the cold competition with excess amount of the unlabelled wild-type probe and by the supershift with an antibody to RelA/p65. Retroviral overexpression of RelA/p65 markedly increased the Adamts5 expression in ATDC5 cells. Furthermore, IL-1b, a putative inducer of the NF-kB signal as well as OA development, enhanced Adamts5 and Rela expressions in ATDC5 cells. The Adamts5 induction by IL-1b was suppressed by the knockdown of Rela through its specific siRNA transfection. Endogenous Adamts5 expression was inhibited by the Rela deletion through adenoviral transfection with Cre in primary articular chondrocytes from mice homozygous for a floxed Rela allele (Rela fl/fl mice). In the ex vivo culture of femoral head cartilage from mesenchymal cell-specific Rela knockout (Prx1-Cre;Rela fl/fl ) mice, the aggrecan fragment release induced by IL-1b was significantly lower than that in the culture from Rela fl/fl mice. Finally, in the experimental mouse OA model, Adamts5 and RelA/p65 were co-localized in chondrocytes of the degraded articular cartilage. Conclusion: We identified RelA/p65 as a potent transcriptional activator of ADAMTS5 in chondrocytes during OA development. The molecular network related to the RelA/p65-ADAMTS5 axis may thus represent a therapeutic target for OA. Our study aimed to investigate the role of TCF/LEF transcription factors in human articular chondrocytes, especially with respect of the crosstalk between TCF/LEF and NF-kB in human chondrocytes. Methods: Human articular chondrocytes were isolated from cartilage of knee joints of healthy donors as well as donors undergoing knee joint replacement due to OA. Various strategies for activation and inhibition of signaling pathways were adopted. Viral transduction was used to overexpress TCF4, LEF1 and TCF3 in human chondrocytes. Total RNA was isolated and cDNA was synthesized, real-time quantitative polymerase chain reaction (qPCR) was performed to evaluate the mRNA expression. Total cell proteins were extracted using RIPA buffer, protein expression of target genes of NF-kB was measured using Western blotting. Co-immunoprecipitation assays were used to study the direct interaction between TCF/LEF and NF-kB. Results: Overexpression of TCF4 induced matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 expression and generic MMP activity in human chondrocytes (figure 1). This was due to potentiating NF-kB signaling by an interaction between TCF4 and NF-kB p65, thereby activating established NF-kB target genes such as MMPs and IL6 (figure
